Drugs from Arthropods: Leveraging Antimicrobial Peptides from Arthropods
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 3815
Special Issue Editor
2. LOEWE Centre for Translational Biodiversity Genomics (LOEWE-TBG), Frankfurt, Germany
Interests: antimicrobial peptides; natural compounds; arthropod immunity; tropical diseases; vector-borne diseases
Special Issue Information
Dear Colleague,
Life-threatening infectious diseases remain among the leading causes of death in the human population worldwide. Multiple outbreaks of epidemic infectious diseases have occurred in the last few decades, including those caused by viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence or re-emergence of such diseases has revealed the deficiency in the pipeline for the discovery and development of anti-infective drugs. One promising solution is the extensive collection of antimicrobial peptides (AMPs), which are valuable because they have evolved for millions of years in multicellular organisms that rely on innate immunity to control and prevent pathogen infection. Arthropods produce the broadest repertoire of AMPs, and their potent antimicrobial, antifungal, antiparasitic, antiviral, and even anticancer, activities in vitro and in vivo have promoted their development as therapeutics. The biotechnological application of arthropod AMPs requires the development of innovative approaches for production, testing and modification of these fascinating molecules.
In this Special Issue, we invite you to prepare and submit your manuscripts describing the chemistry of AMPs from arthropods, their biological activities and modes of action, AMP mimetics and related topics.
Dr. Miray Tonk
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial peptides
- host-defense peptides
- antiinfective
- antibacterial
- antibiofilm
- antifungal
- antiviral
- antiparasitic
- anticancer
- AMPs with synergistic activities
